Cargando…

The lymph node ratio predicts cancer-specific survival of node-positive non-small cell lung cancer patients: a population-based SEER analysis

BACKGROUND: Lymph node ratio (LNR) has been suggested to be an effective prognostic tool for stratifying non-small cell lung cancer (NSCLC) cases. In this study, we sought to determine cancer-specific survival (CCS) of NSCLC cases from the SEER registry and used the X-tile method to optimize CCS-bas...

Descripción completa

Detalles Bibliográficos
Autores principales: Kai, Liu, Zhoumiao, Chen, Shaohua, Xu, Zhao, Chen, Zhijun, Li, Zhengfu, He, Xiujun, Cai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7814600/
https://www.ncbi.nlm.nih.gov/pubmed/33468199
http://dx.doi.org/10.1186/s13019-020-01390-x
_version_ 1783638085675778048
author Kai, Liu
Zhoumiao, Chen
Shaohua, Xu
Zhao, Chen
Zhijun, Li
Zhengfu, He
Xiujun, Cai
author_facet Kai, Liu
Zhoumiao, Chen
Shaohua, Xu
Zhao, Chen
Zhijun, Li
Zhengfu, He
Xiujun, Cai
author_sort Kai, Liu
collection PubMed
description BACKGROUND: Lymph node ratio (LNR) has been suggested to be an effective prognostic tool for stratifying non-small cell lung cancer (NSCLC) cases. In this study, we sought to determine cancer-specific survival (CCS) of NSCLC cases from the SEER registry and used the X-tile method to optimize CCS-based LNR cut-off points for prognostic stratification of node-positive NSCLC. METHODS: CSS and other clinicopathologic variables were retrieved from the SEER registry. Kaplan-Meier methods were used to calculate CSS. The optimal cut-off points for LNR classification were determined by the X-tile approach. Multivariate Cox regression analysis was performed to identify independent risks of CSS. RESULTS: Totally 11,341 lung cancer patients were included. Their median CSS was 22 months (range 0,143). The median LNR was 0.22 (Q1,Q3: 0.11, 0.50). X-tile analysis showed that the optimal LNR cut-off points were 0.28 and 0.81, dividing the cohort into low (LNR1 ≤ 0.28; n = 6580, 58%), middle (0.28 < LNR2 < 0.81; n = 3025, 26.7%), and high (LNR3 > 0.81; n = 1736, 15.3%) subsets. Kaplan-Meier analysis showed that patients with a low LNR had a significantly higher CCS versus patients with middle or high LNR (P < 0.001). Multivariate competing risks regression analysis revealed that LNR was an independent and significant adverse predictor of CSS (LNR2 vs. LNR1: SHR: 1.56, 95%CI: 1.47,1.67, P < 0.001; LNR3 vs. LNR1: SHR: 2.54, 95%CI: 2.30,2.80, P < 0.001). CONCLUSIONS: LNR is an independent prognostic factor of node-positive NSCLC and its optimal cut-off values established using the robust x-tile method effectively define subpopulations of node-positive NSCLC cases, which is important in guiding selection of treatment strategies clinically. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13019-020-01390-x.
format Online
Article
Text
id pubmed-7814600
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-78146002021-01-19 The lymph node ratio predicts cancer-specific survival of node-positive non-small cell lung cancer patients: a population-based SEER analysis Kai, Liu Zhoumiao, Chen Shaohua, Xu Zhao, Chen Zhijun, Li Zhengfu, He Xiujun, Cai J Cardiothorac Surg Research Article BACKGROUND: Lymph node ratio (LNR) has been suggested to be an effective prognostic tool for stratifying non-small cell lung cancer (NSCLC) cases. In this study, we sought to determine cancer-specific survival (CCS) of NSCLC cases from the SEER registry and used the X-tile method to optimize CCS-based LNR cut-off points for prognostic stratification of node-positive NSCLC. METHODS: CSS and other clinicopathologic variables were retrieved from the SEER registry. Kaplan-Meier methods were used to calculate CSS. The optimal cut-off points for LNR classification were determined by the X-tile approach. Multivariate Cox regression analysis was performed to identify independent risks of CSS. RESULTS: Totally 11,341 lung cancer patients were included. Their median CSS was 22 months (range 0,143). The median LNR was 0.22 (Q1,Q3: 0.11, 0.50). X-tile analysis showed that the optimal LNR cut-off points were 0.28 and 0.81, dividing the cohort into low (LNR1 ≤ 0.28; n = 6580, 58%), middle (0.28 < LNR2 < 0.81; n = 3025, 26.7%), and high (LNR3 > 0.81; n = 1736, 15.3%) subsets. Kaplan-Meier analysis showed that patients with a low LNR had a significantly higher CCS versus patients with middle or high LNR (P < 0.001). Multivariate competing risks regression analysis revealed that LNR was an independent and significant adverse predictor of CSS (LNR2 vs. LNR1: SHR: 1.56, 95%CI: 1.47,1.67, P < 0.001; LNR3 vs. LNR1: SHR: 2.54, 95%CI: 2.30,2.80, P < 0.001). CONCLUSIONS: LNR is an independent prognostic factor of node-positive NSCLC and its optimal cut-off values established using the robust x-tile method effectively define subpopulations of node-positive NSCLC cases, which is important in guiding selection of treatment strategies clinically. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13019-020-01390-x. BioMed Central 2021-01-19 /pmc/articles/PMC7814600/ /pubmed/33468199 http://dx.doi.org/10.1186/s13019-020-01390-x Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Kai, Liu
Zhoumiao, Chen
Shaohua, Xu
Zhao, Chen
Zhijun, Li
Zhengfu, He
Xiujun, Cai
The lymph node ratio predicts cancer-specific survival of node-positive non-small cell lung cancer patients: a population-based SEER analysis
title The lymph node ratio predicts cancer-specific survival of node-positive non-small cell lung cancer patients: a population-based SEER analysis
title_full The lymph node ratio predicts cancer-specific survival of node-positive non-small cell lung cancer patients: a population-based SEER analysis
title_fullStr The lymph node ratio predicts cancer-specific survival of node-positive non-small cell lung cancer patients: a population-based SEER analysis
title_full_unstemmed The lymph node ratio predicts cancer-specific survival of node-positive non-small cell lung cancer patients: a population-based SEER analysis
title_short The lymph node ratio predicts cancer-specific survival of node-positive non-small cell lung cancer patients: a population-based SEER analysis
title_sort lymph node ratio predicts cancer-specific survival of node-positive non-small cell lung cancer patients: a population-based seer analysis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7814600/
https://www.ncbi.nlm.nih.gov/pubmed/33468199
http://dx.doi.org/10.1186/s13019-020-01390-x
work_keys_str_mv AT kailiu thelymphnoderatiopredictscancerspecificsurvivalofnodepositivenonsmallcelllungcancerpatientsapopulationbasedseeranalysis
AT zhoumiaochen thelymphnoderatiopredictscancerspecificsurvivalofnodepositivenonsmallcelllungcancerpatientsapopulationbasedseeranalysis
AT shaohuaxu thelymphnoderatiopredictscancerspecificsurvivalofnodepositivenonsmallcelllungcancerpatientsapopulationbasedseeranalysis
AT zhaochen thelymphnoderatiopredictscancerspecificsurvivalofnodepositivenonsmallcelllungcancerpatientsapopulationbasedseeranalysis
AT zhijunli thelymphnoderatiopredictscancerspecificsurvivalofnodepositivenonsmallcelllungcancerpatientsapopulationbasedseeranalysis
AT zhengfuhe thelymphnoderatiopredictscancerspecificsurvivalofnodepositivenonsmallcelllungcancerpatientsapopulationbasedseeranalysis
AT xiujuncai thelymphnoderatiopredictscancerspecificsurvivalofnodepositivenonsmallcelllungcancerpatientsapopulationbasedseeranalysis
AT kailiu lymphnoderatiopredictscancerspecificsurvivalofnodepositivenonsmallcelllungcancerpatientsapopulationbasedseeranalysis
AT zhoumiaochen lymphnoderatiopredictscancerspecificsurvivalofnodepositivenonsmallcelllungcancerpatientsapopulationbasedseeranalysis
AT shaohuaxu lymphnoderatiopredictscancerspecificsurvivalofnodepositivenonsmallcelllungcancerpatientsapopulationbasedseeranalysis
AT zhaochen lymphnoderatiopredictscancerspecificsurvivalofnodepositivenonsmallcelllungcancerpatientsapopulationbasedseeranalysis
AT zhijunli lymphnoderatiopredictscancerspecificsurvivalofnodepositivenonsmallcelllungcancerpatientsapopulationbasedseeranalysis
AT zhengfuhe lymphnoderatiopredictscancerspecificsurvivalofnodepositivenonsmallcelllungcancerpatientsapopulationbasedseeranalysis
AT xiujuncai lymphnoderatiopredictscancerspecificsurvivalofnodepositivenonsmallcelllungcancerpatientsapopulationbasedseeranalysis